DocGo Inc. Unrealized Gain (Loss) on Derivatives and Commodity Contracts
DocGo Inc. (DCGO) reported Unrealized Gain (Loss) on Derivatives and Commodity Contracts of $0 for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivativesAndCommodityContracts · last filed 2023-11-06
- DocGo Inc. unrealized gain (loss) on derivatives and commodity contracts for the quarter ending 2023-09-30 was $0.00.
- DocGo Inc. unrealized gain (loss) on derivatives and commodity contracts for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. unrealized gain (loss) on derivatives and commodity contracts for the quarter ending 2022-09-30 was -$1.83M.
- DocGo Inc. unrealized gain (loss) on derivatives and commodity contracts for the quarter ending 2022-06-30 was $3.03M.
| Period end | Unrealized Gain (Loss) on Derivatives and Commodity Contracts 3 month | Unrealized Gain (Loss) on Derivatives and Commodity Contracts 6 month | Unrealized Gain (Loss) on Derivatives and Commodity Contracts 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-06 | $0.00 10-Q · filed 2023-11-06 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | |
| 2022-09-30 | -$1.83M 10-Q · filed 2023-11-06 | $1.20M derived: sum of 2 quarters · filed 2023-11-06 | $1.14M 10-Q · filed 2023-11-06 |
| 2022-06-30 | $3.03M 10-Q · filed 2023-08-08 | $2.97M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | -$58.75K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |